DM
Derek J Maetzold
Pres. & Chief Exec. OfficerDirector

Derek J Maetzold insider trades: Castle Biosciences (CSTL) stock sales

Pres. & Chief Exec. Officer, Castle Biosciences Last trade Nov 2, 2026 197 Form 4 filings
$8.9M
Sold, last 12 months
75 sales
$0
Bought, last 12 months
0 buys
550
Open-market trades
since 2005
2
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Derek reports to the SEC

Open-market buys and sales

550 trades reported on SEC Form 4, newest first

DateStockTypeValue
Nov 2, 2026CSTL↓ Sell$310K
Nov 2, 2026CSTL↓ Sell$115K
Nov 2, 2026CSTL↓ Sell$98K
Oct 19, 2026CSTL↓ Sell$274K
Oct 19, 2026CSTL↓ Sell$102K
Oct 19, 2026CSTL↓ Sell$87K
Oct 5, 2026CSTL↓ Sell$305K
Oct 5, 2026CSTL↓ Sell$114K
Oct 5, 2026CSTL↓ Sell$97K
Sep 21, 2026CSTL↓ Sell$303K
Sep 21, 2026CSTL↓ Sell$113K
Sep 21, 2026CSTL↓ Sell$96K
Sep 11, 2026CSTL↓ Sell$275K
Sep 11, 2026CSTL↓ Sell$103K
Sep 11, 2026CSTL↓ Sell$87K
Aug 28, 2026CSTL↓ Sell$413K
Aug 28, 2026CSTL↓ Sell$90K
Aug 28, 2026CSTL↓ Sell$77K
Aug 28, 2026CSTL↓ Sell$28K
Aug 28, 2026CSTL↓ Sell$9K
Aug 3, 2026CSTL↓ Sell$519K
Aug 3, 2026CSTL↓ Sell$188K
Aug 3, 2026CSTL↓ Sell$160K
Jul 14, 2026CSTL↓ Sell$31K
Jul 14, 2026CSTL↓ Sell$26K
Jul 14, 2026CSTL↓ Sell$19K
Jul 14, 2026CSTL↓ Sell$13K
Jul 14, 2026CSTL↓ Sell$6K
Jul 1, 2026CSTL↓ Sell$151K
Jul 1, 2026CSTL↓ Sell$33K
Jul 1, 2026CSTL↓ Sell$28K
Jul 1, 2026CSTL↓ Sell$20K
Jul 1, 2026CSTL↓ Sell$7K
Jun 15, 2026CSTL↓ Sell$28K
Jun 15, 2026CSTL↓ Sell$24K
Jun 15, 2026CSTL↓ Sell$17K
Jun 15, 2026CSTL↓ Sell$11K
Jun 15, 2026CSTL↓ Sell$6K
Jun 1, 2026CSTL↓ Sell$130K
Jun 1, 2026CSTL↓ Sell$28K
Jun 1, 2026CSTL↓ Sell$24K
Jun 1, 2026CSTL↓ Sell$17K
Jun 1, 2026CSTL↓ Sell$6K
May 21, 2026CSTL↓ Sell$27K
May 21, 2026CSTL↓ Sell$23K
May 21, 2026CSTL↓ Sell$17K
May 21, 2026CSTL↓ Sell$11K
May 21, 2026CSTL↓ Sell$6K
May 7, 2026CSTL↓ Sell$138K
May 7, 2026CSTL↓ Sell$30K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other CSTL insiders

Open-market trades in the last 12 months

About Derek J Maetzold's insider trades

Derek J Maetzold is Pres. & Chief Exec. Officer at Castle Biosciences (CSTL). Since May 26, 2005, Derek has reported no open-market purchases and 550 sales worth $94.3M on SEC Form 4. In the last 12 months: 75 sales ($8.9M).

Their filings also include option exercises (25 filings), grants and awards (13 filings), shares withheld for taxes (9 filings), gifts (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CSTL insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.